An experimental animal study.
To investigate histomorphometric and radiographical changes in the BB.4S rat model after PEEK (polyetheretherketone) nonfusion interspinous device implantation.
Clinical effectiveness of the PEEK nonfusion spine implant Wallis (Abbott, Bordeaux, France; now Zimmer, Warsaw, IN) is well documented. However, there is a lack of evidence on the long-term effects of this implant on bone, in particular its influence on structural changes of bone elements of the lumbar spine.
Twenty-four male BB.4S rats aged 11 weeks underwent surgery for implantation of a PEEK nonfusion interspinous device or for a sham procedure in 3 groups of 8 animals each: 1) implantation at level L4–L5; 2) implantation at level L5–L6; and 3) sham surgery. Eleven weeks postoperatively osteolyses at the implant-bone interface were measured via radiograph, bone mineral density of vertebral bodies was analyzed using osteodensitometry, and bone mineral content as well as resorption of the spinous processes were examined by histomorphometry.
Resorption of the spinous processes at the site of the interspinous implant was found in all treated segments. There was no significant difference in either bone density of vertebral bodies or histomorphometric structure of the spinous processes between adjacent vertebral bodies, between treated and untreated segments and between groups.
These findings indicate that resorption of spinous processes because of a result of implant loosening, inhibit the targeted load redistribution through the PEEK nonfusion interspinous device in the lumbar spinal segment of the rat. This leads to reduced long-term stability of the implant in the animal model. These results suggest that PEEK nonfusion interspinous devices like the Wallis implants may have time-limited effects and should only be used for specified indications.
Resorption of spinous processes at the site of PEEK (polyetheretherketone) nonfusion interspinous devices was found in the rat model. Resorption of spinous processes inhibits load redistribution resulting in reduced long-term effects of these implants. This suggests that Wallis implants may have time-limited effects and should only be used for specified indications.
*Department of Orthopaedic Surgery, Asklepios Klinikum Uckermark, Schwedt/Oder, Germany
†Department of Trauma and Reconstructive Surgery, University Medicine, University of Greifswald, Karlsburg, Germany
‡Western Australian Institute for Medical Research (WAIMR), University of Western Australia, Nedlands, Australia
§NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia
¶MEM Research Center, Institute for Evaluative Research in Orthopaedic Surgery, University of Berne, Berne, Switzerland
‖Department of Orthopaedic Surgery, University Medicine, University of Greifswald, Karlsburg, Germany
**Department of Laboratory Animal Science, University Medicine, University of Greifswald, Karlsburg, Germany
††Orthopaedic Clinic, Pfeiffersche Stiftungen, Magdeburg, Germany.
Address correspondence and reprint requests to Markus Melloh, MD, MPH, PhD, Western Australian Institute for Medical Research (WAIMR), University of Western Australia, B Block, QEII Medical Centre, Hospital Avenue, Nedlands WA 6009, Australia; E-mail: firstname.lastname@example.org
Acknowledgment date: April 18, 2012. First revision date: July 6, 2012. Acceptance date: November 29, 2012.
The device(s)/drug(s) is/are FDA-approved or approved by corresponding national agency for this indication.
No funds were received in support of this work.
No relevant financial activities outside the submitted work.